Nature's Sunshine to Buy Out Fosun's 20 Percent Stakes in China Joint Ventures for 7 Million Dollars

Nature's Sunshine Products disclosed in a regulatory filing that it has agreed to buy Fosun Industrial's minority interests in its two China joint ventures for a combined 7.0 million dollars in cash, giving the herbal supplement maker sole ownership of its business in the country.

Under share purchase agreements signed June 30, 2025, Nature's Sunshine will pay 3.9 million dollars for Fosun's interest in Nature's Sunshine Hong Kong Limited and 3.1 million dollars for its interest in Shanghai Nature's Sunshine Health Products Co. The joint ventures, formed in 2014 with Shanghai Fosun Pharmaceutical, have been owned 80 percent by Nature's Sunshine and 20 percent by Fosun Industrial and market the company's products in China.

The operating agreements required the buyout once Fosun Pharma and its affiliates owned less than 5 percent of Nature's Sunshine's common stock. That threshold was crossed on June 27, 2025, when a Fosun affiliate sold 2,854,607 shares in a secondary offering. The purchases are subject to customary closing conditions, including regulatory submissions to China's State Administration for Market Regulation and Ministry of Commerce.